Main Article Content

Евгения Алексеевна Созуракова
Алексей Павлович Чащин
Вадим Гельевич Мозес
Светлана Ивановна Елгина
Елена Владимировна Рудаева
Кира Борисовна Мозес
Наталья Степановна Черных

Abstract

The aim of the study is to systematize the literature data on the principles and approaches to the treatment of neurotrophic keratitis.
Materials and methods. When compiling the literature review, an assessment of the information databases PubMed, e-library was carried out. Search words for literature sources: «neurotrophic keratitis», «trophic corneal ulcer», «neurotrophic keratopathy».
Research results. According to the results of the search of electronic information databases, 809 sources were found: 777 in PubMed, and 32 in e-library. 758 sources were excluded from the analysis: 390 due to the lack of full free access to the publication text, 120 due to the lack of a full version of the publication, and 248 due to the mismatch between the title and the publication. 51 publications met the search criteria.
Neurotrophic keratitis (NK) is a degenerative disease of the cornea that is accompanied by neurogenic inflammation. The main cause of the disease is a disorder of sensory innervation, which is provided by the trigeminal nerve at any point along its course. Traditional therapy, which includes antiseptics, tear substitutes, and corneoprotectors, is primarily aimed at stimulating regenerative processes in the cornea and preventing further progression of the disease, but it does not address the underlying cause and is often insufficiently effective. The current management strategy for patients with NTC requires a comprehensive approach based on the stage and severity of the disease. Systematization of current methods has revealed significant progress in therapy: conservative treatment increasingly includes biological drugs (autologous blood serum, growth factors), recombinant neurotrophic factors, and a wider range of traditional drugs (tear substitutes and reparants), while the arsenal of surgical methods has been expanded with effective interventions such as various types of keratoplasties, corneal neurotization, and corneal transplants. transplantation of limbal cells.
Conclusion. The use of the latest techniques has significantly expanded the possibilities of treating patients with severe forms of NTC.

Keywords

neurotrophic keratitis, corneal ulcer, recombinant nerve growth factor, insulin, autologous serum, corneal neurotization, limbal stem cell transplantation

Author Biographies

Евгения Алексеевна Созуракова,
сandidate of medical sciences, lecturer, department of internal medicine; ophthalmologist of the surgical department № 4
Алексей Павлович Чащин,
ophthalmologist of the surgical department № 5
Вадим Гельевич Мозес,
doctor of medical sciences, professor, director of the medical institute
Светлана Ивановна Елгина,
doctor of medical sciences, docent, professor of the department of obstetrics and gynecology named after G.A. Ushakova
Елена Владимировна Рудаева,
candidate of medical sciences, docent, docent of the department of obstetrics and gynecology named after G.A. Ushakova
Кира Борисовна Мозес,
assistant of the department of polyclinic therapy and nursing
Наталья Степановна Черных,
candidate of medical sciences, docent, docent of the department of polyclinic pediatrics, propaedeutics of childhood diseases and postgraduate training

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Созуракова, Е. А., Чащин, А. П., Мозес, В. Г., Елгина, С. И., Рудаева, Е. В., Мозес, К. Б., & Черных, Н. С. (2025). MODERN PRINCIPLES OF TREATMENT OF NEUROTROPHIC KERATITIS: REVIEW LITERATURE. Medicine in Kuzbass, 24(4), 21-31. https://doi.org/10.24412/2687-0053-2025-4-21-31

References

Dua HS, Said DG, Messmer EM, Rolando M, Benitez-Del-Castillo JM, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018; 66: 107-131. doi:10.1016/j.preteyeres.2018.04.003

Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000; 107(7): 1347-1352. doi:10.1016/s0161-6420(00)00163-9

Darwish T, Brahma A, O'Donnell C, Efron N. Subbasal nerve fiber regeneration after LASIK and LASEK assessed by noncontact esthesiometry and in vivo confocal microscopy: prospective study. J Cataract Refract Surg. 2007; 33(9): 1515-1521. doi:10.1016/j.jcrs.2007.05.023

Ozaki K, Terayama Y, Matsuura T. Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. Invest Ophthalmol Vis Sci. 2018; 59(15): 5868-5875. doi:10.1167/iovs.18-25693

Zhurova S. Neurotrophic corneal and conjunctival xerosis. Ophthalmology Reports. 2014; 7(1): 59-65. Russian (Журова С.Г. Нейротрофический роговично-конъюнктивальный ксероз //Офтальмологические ведомости. 2014. Т. 7, № 1. C. 59-65.) doi: 10.17816/OV2014159-65

Müller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003; 76(5): 521-542. doi: 10.1016/s0014-4835(03)00050-2

Sigelman S, Friedenwald JS. Mitotic and wound-healing activities of the corneal epithelium; effect of sensory denervation. AMA Arch Ophthalmol. 1954; 52(1): 46-57. doi: 10.1001/archopht.1954.00920050048005

Ruiz-Lozano RE, Hernandez-Camarena JC, Loya-Garcia D, Merayo-Lloves J, Rodriguez-Garcia A. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review. Ocul Surf. 2021; 19: 224-240. doi: 10.1016/j.jtos.2020.09.007

Versura P, Giannaccare G, Pellegrini M, Sebastiani S, Campos EC. Neurotrophic keratitis: current challenges and future prospects. Eye Brain. 2018; 10: 37-45. doi: 10.2147/EB.S117261

Heigle TJ, Pflugfelder SC. Aqueous tear production in patients with neurotrophic keratitis. Cornea. 1996; 15(2): 135-138. doi: 10.1097/00003226-199603000-00005

Bonini S, Aloe L, Bonini S, Rama P, Lamagna A, Lambiase A. Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface. Advances in experimental medicine and biology. 2002; 506(Pt. A): 531-537. doi: 10.1007/978-1-4615-0717-8_75

Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond). 2003; 17(8): 989-995. doi: 10.1038/sj.eye.6700616

Mackie IA. Neuroparalytic keratitis. Current Ocular Therapy. 1995; 452-454

Egorov EA. Features of dry eye syndrome treatment. RMJ. Clinical ophthalmology. 2018; 3: 146-149. Russian (Егоров Е.А. Особенности терапии синдрома «сухого глаза» //РМЖ. Клиническая офтальмология. 2018; Т. 3, С. 146-149.) doi: 10.21689/2311-7729-2018-18-3-146-149

Trinh T, Santaella G, Mimouni M, Mednick Z, Cohen E, Sorkin N, et al. Assessment of response to multimodal management of neurotrophic corneal disease. Ocul Surf. 2021; 19: 330-335. doi: 10.1016/j.jtos.2020.11.003

Brzheskiĭ VV, Radkhuan MR. Relative effectiveness of methods of obturating the lacrimal duct in the treatment of patients with dry eye syndrome. Russian Annals of Ophthalmology. 2019; 135(1): 12-20. Russian (Бржеский В.В., Радхуан М.Р. Сравнительная эффективность методов обтурации слезоотводящих путей в лечении пациентов с синдромом сухого глаза //Вестник офтальмологии. 2019; Т. 135, № 1, C. 12-20.) doi: 10.17116/oftalma201913501112

Riks IA, Trufanov SV, Boutaba R. Modern approaches to the treatment of meibomian gland dysfunction. Russian Annals of Ophthalmology. 2021; 137(1): 130-136. Russian (Рикс И.А., Труфанов С.В., Бутаба Р. Современные подходы к лечению дисфункции мейбомиевых желез //Вестник офтальмологии. 2021; Т. 137, № 1, С. 130-136.) doi: 10.17116/oftalma2021137011130

Witsberger E, Schornack M. Scleral Lens Use in Neurotrophic Keratopathy: A Review of Current Concepts and Practice. Eye Contact Lens. 2021; 47(3):144-148. doi: 10.1097/ICL.0000000000000748

Rauz S, Saw VP. Serum eye drops, amniotic membrane and limbal epithelial stem cells-tools in the treatment of ocular surface disease. Cell Tissue Bank. 2010; 11(1): 13-27. doi: 10.1007/s10561-009-9128-1

Semeraro F, Forbice E, Romano V, Angi M, Romano MR, Filippelli ME, et al. Neurotrophic keratitis. Ophthalmologica. 2014; 231(4): 191-197. doi: 10.1159/000354380

Pozdeeva NA, Domentyeva LN, Vasilyeva AY, Ovchinnikova VN. Using the autologous serum in ocular surface diseases. Practical medicine. 2014; 1(77): 111-115. Russian (Поздеева Н.А., Доментьева Л.Н., Васильева А.Ю., Овчинникова В.Н. Применение аутологичной сыворотки при заболеваниях глазной поверхности //Практическая медицина. 2014; № 1(77). С. 111-115)

Mussano F, Genova T, Munaron L, Petrillo S, Erovigni F, Carossa S. Cytokine, chemokine, and growth factor profile of platelet-rich plasma. Platelets. 2016; 27(5): 467-471. doi: 10.3109/09537104.2016.1143922

Loshkareva AO, Maychuk DY. Use of Platelet-rich Plasma in Patients with Chronic Corneal Erosions. Modern Technologies in Ophthalmology. 2016; 4: 131-132. Russian (Лошкарева А.О., Майчук Д.Ю. Применение богатой тромбоцитами плазмы у пациентов с хроническими эрозиями роговицы //Современные технологии в офтальмологии. 2016. № 4. С. 388-393)

Wróbel-Dudzińska D, Alio J, Rodriguez A, Suchodoła-Ratajewicz E, Kosior-Jarecka E, Rymgayłło-Jankowska B, et al. Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer. J Ophthalmol. 2018; 2018: 3538764. doi: 10.1155/2018/3538764

Arvola RP, Robciuc A, Holopainen JM. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers. Cornea. 2016; 35(4): 451-455. doi: 10.1097/ICO.0000000000000759

Cochener B, Zagnoli C, Hugny-Larroque C, Derrien S. Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent. J Fr Ophtalmol. 2019; 42(2): 159-165. doi: 10.1016/j.jfo.2018.05.009

Sheha H, Tighe S, Hashem O, Hayashida Y. Update On Cenegermin Eye Drops In The Treatment Of Neurotrophic Keratitis. Clin Ophthalmol. 2019; 13: 1973-1980. doi: 10.2147/OPTH.S185184

Deeks ED, Lamb YN. Cenegermin: A Review in Neurotrophic Keratitis. Drugs. 2020; 80(5): 489-494. doi: 10.1007/s40265-020-01289-w

Pflugfelder SC, Massaro-Giordano M, Perez VL, Hamrah P, Deng SX, Espandar L, et al. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Ophthalmology. 2020; 127(1): 14-26. doi: 10.1016/j.ophtha.2019.08.020

Roszkowska AM, Inferrera L, Aragona E, Gargano R, Postorino EI, Aragona P. Clinical and instrumental assessment of the corneal healing in moderate and severe neurotrophic keratopathy treated with rh-NGF (Cenegermin). Eur J Ophthalmol. 2022; 32(6): 3402-3410. doi: 10.1177/11206721221097584

Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol. 2007; 125(8): 1082-1088. doi: 10.1001/archopht.125.8.1082

Mancini A, Mancini M, Taloni A, Bifezzi L, Romeo MA, Rijillo L, et al. Topical insulin used alone or in combination with drug-depository contact lens for refractory cases of neurotrophic keratopathy. Am J Ophthalmol Case Rep. 2024; 36: 102227. doi: 10.1016/j.ajoc.2024.102227

Yamada N, Yanai R, Kawamoto K, Nagano T, Nakamura M, Inui M, Nishida T. Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1. Invest Ophthalmol Vis Sci. 2006; 47(8): 3286-3292. doi: 10.1167/iovs.05-1205

Kondo S, Okano Y, Iraha S, Tokunaga S. Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial. Ophthalmol Sci. 2024; 5(2): 100634. doi: 10.1016/j.xops.2024.100634

Gusek-Schneider GC, Erbguth F. Protective ptosis by botulinum A toxin injection in corneal affectations. Klin Monbl Augenheilkd. 1998; 213(1): 15-22. doi: 10.1055/s-2008-1034938

Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011; 108(14): 243-248. doi: 10.3238/arztebl.2011.0243

Rodríguez-Ares MT, Touriño R, López-Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea. 2004; 23(6): 577-583. doi: 10.1097/01.ico.0000121709.58571.12

Kasparova EvgA, Kasparov AA, Sobkova OI, Kasparova ЕlА, Rozinova VN. A method of treating purulent corneal ulcer in the eyes with neuroparalytical keratitis and lagophthalmos. Russian Annals of Ophthalmology. 2019; 135(5-2): 220 225. Russian (Каспарова Евг.А., Каспарова А.А., Собкова О.И., Каспарова Ел.А., Розинова В.Н. Способ лечения гнойной язвы роговицы, развившейся на глазах с нейротрофическим кератитом и лагофтальмом //Вестник офтальмологии. 2019; Т. 135. № 5-2. С. 220 225.) doi: 10.17116/oftalma2019135052220

Kymionis GD, Vakalopoulos DG, Chatzea MS, Togka KA, Tsagkogiannis VA, Petrou PC. Allogeneic anterior lens capsule transplantation (ALCT) for the management of HSV neurotrophic keratitis. Am J Ophthalmol Case Rep. 2025; 38: 102292. doi: 10.1016/j.ajoc.2025.102292

Bains RD, Elbaz U, Zuker RM, Ali A, Borschel GH. Corneal neurotization from the supratrochlear nerve with sural nerve grafts: a minimally invasive approach. Plast Reconstr Surg. 2015; 135(2): 397-400. doi: 10.1097/PRS.0000000000000994

Elbaz U, Bains R, Zuker RM, Borschel GH, Ali A. Restoration of corneal sensation with regional nerve transfers and nerve grafts: a new approach to a difficult problem. JAMA Ophthalmol. 2014; 132(11): 1289-1295. doi: 10.1001/jamaophthalmol.2014.2316

Yelgina SI, Ushakova GA, Nikulina EN. Reproductive system in full-term and preterm newborn girls. Fundamental and clinical medicine. 2016; 1(3): 39-45. Russian (Елгина С.И., Ушакова Г.А., Никулина Е.Н. Репродуктивная система доношенных и недоношенных новорожденных девочек //Фундаментальная и клиническая медицина. 2016. Т. 1, № 3. С. 39-45)

Gushchina MB, Butsan SB, Sergeeva VY, Salikhov KS, Tereshchenko AV, Erokhina EV, Mal’kov SA. Results of neurotrophic keratopathy treatment by direct corneal neurotization. Fyodorov Journal of Ophthalmic Surgery. 2023; 3S: 37-48. Russian (Гущина М.Б., Буцан С.Б., Сергеева В.Ю., Салихов К.С., Терещенко А.В., Ерохина Е.В., Мальков С.А. Результаты хирургического лечения нейротрофической кератопатии методом прямой невротизации роговицы //Офтальмохирургия. 2023. № 3S. C. 37-48.) doi: 10.25276/0235-4160-2023-3S-37-48

Kengpunpanich S, Chirapapaisan C, Ngowyutagon P, Chotikavanich S, Sikarinkul R, Taetrongchit N, et al. Comparative analysis of long-term results of three epithelial cell transplantation procedures for treating limbal stem cell deficiency. Ocul Surf. 2024; 32: 71-80. doi: 10.1016/j.jtos.2024.01.003

Sangwan VS, Basu S, MacNeil S, Balasubramanian D. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency. Br J Ophthalmol. 2012; 96(7): 931-934. doi: 10.1136/bjophthalmol-2011-301164

Nakamura T, Inatomi T, Sotozono C, Amemiya T, Kanamura N, Kinoshita S. Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol. 2004; 88(10): 1280-1284. doi: 10.1136/bjo.2003.038497

Jurkunas UV, Yin J, Johns LK, Li S, Negre H, Shaw KL, et al. Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety. Sci Adv. 2023; 9(33): eadg6470. doi: 10.1126/sciadv.adg6470

Elalfy M, Elsawah K, Maqsood S, Jordan N, Hassan M, Zaki A, et al. Allogenic Cultured Limbal Epithelial Transplantation and Cultivated Oral Mucosal Epithelial Transplantation in Limbal Stem Cells Deficiency: A Comparative Study. Ophthalmology and Therapy. 2025; 14(2): 413-432. doi: 10.1007/s40123-024-01083-x

Shanbhag SS, Patel CN, Goyal R, Donthineni PR, Singh V, Basu S. Simple limbal epithelial transplantation (SLET): Review of indications, surgical technique, mechanism, outcomes, limitations, and impact. Indian J Ophthalmol. 2019; 67(8): 1265-1277. doi: 10.4103/ijo.IJO_117_19

Basu S, Sureka SP, Shanbhag SS, Kethiri AR, Singh V, Sangwan VS. Simple Limbal Epithelial Transplantation: Long-Term Clinical Outcomes in 125 Cases of Unilateral Chronic Ocular Surface Burns. Ophthalmology. 2016; 123(5): 1000-1010. doi: 10.1016/j.ophtha.2015.12.042

Ganger A, Singh A, Kalaivani M, Gupta N, Vanathi M, Mohanty S, Tandon R. Outcomes of surgical interventions for the treatment of limbal stem cell deficiency. Indian J Med Res. 2021; 154(1): 51-61. doi: 10.4103/ijmr.IJMR_1139_18

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>